Bone mineral density in progestogen-only implant and pill users with amenorrhoea: a pilot study
| Autor: | Anne Johnstone, Rosemary Cochrane, Rebecca Heller, Anna Glasier, Sharon Cameron |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
medicine.medical_treatment Long-acting reversible contraception Pilot Projects Bone Density Good evidence medicine Contraceptive Agents Female Humans Ovarian follicle Amenorrhea reproductive and urinary physiology Bone mineral Progestogen Obstetrics business.industry Obstetrics and Gynecology female genital diseases and pregnancy complications medicine.anatomical_structure Reproductive Medicine Hormonal contraception Pill Female Implant Progestins business hormones hormone substitutes and hormone antagonists |
| Zdroj: | BMJ sexualreproductive health. 48(1) |
| ISSN: | 2515-2009 |
| Popis: | Although there is good evidence that the progestogen-only injectable is associated with a decrease in bone mineral density (BMD), there is a lack of data pertaining to lower dose progestogen-only methods.1 2 The recent guidance from the Clinical Effectiveness Unit of the Faculty of Sexual and Reproductive Healthcare advises that current evidence is too limited to confirm or exclude an association between implant use and a reduction in BMD.3 Amenorrhoea results from suppression of ovarian follicle growth and of oestrogen secretion.4 It is therefore possible that amenorrhoeic women using any systemic progestogen-only contraception that suppresses ovarian activity may be more at … |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|